Skip to content

Phase II trial of conversion surgery for unresectable gastric cancer

Phase II trial of conversion surgery for unresectable gastric cancer - Conversion surgery for gastric cancer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014251
Enrollment
25
Registered
2014-06-12
Start date
2014-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

gastrectomy

Sponsors

Chubu Clinical Oncology Group (CCOG)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed gastric cancer 2) Clinically diagnosed unresectable gastric cancer patients performed chemotherapy 3) No history of gastrectomy 4) Clinically diagnosed resectable after chemotherapy 5) Age between 20 and 80 at registration 6) Performance Status(ECOG) 0 or 1 7) Fair oral intake 8) Adequate organ functions 9) Written informed consent from patient

Exclusion criteria

Exclusion criteria: 1) Synchronous other cancer 2) Female with present pregnancy or breast-feeding, or contemplating pregnancy 3) Mental disorders which may affect ability or willingness to provide informed consent of the study 4) Continuous systemic steroid therapy 5) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema 6) Active bacterial or fungal infection 7) Past history of myocardial infarction or unstable angina within 6 months 8) Uncontrollable hypertension

Design outcomes

Primary

MeasureTime frame
3 year survival rate

Secondary

MeasureTime frame
5 year survival rate, curative resection rate of conversion surgery, 3 year survival rate from conversion surgery, pathological response, adverse event

Countries

Japan

Contacts

Public ContactSeij Ito

Aichi Cancer Center Hospital Department of Gastroenterological Surgery

seito@aichi-cc.jp0527626111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026